Trump and COVID-19: treatments to date

05-Oct-2020 - Last updated on 06-Oct-2020 at 15:50 GMT

(Vacclav/iStock via Getty Images Plus)

Related tags COVID-19 Coronavirus Regeneron Gilead Lilly Novartis

With the virus reaching the Oval Office, the presidential diagnosis is shining a spotlight on some of the drugs reportedly administered to the POTUS.

When news of US President Donald Trump’s positive COVID-19 test broke on the 24-hour news cycle in the wee hours of Friday morning, mainstream media scrambled for details about when he tested positive, severity of his case, and particulars of his treatment plan. Press conferences by doctors at Walter Reed National Military Medical Center (WRMC, the hospital Trump was whisked away to) and tweets from the Commander in Chief led to as much confusion as they did clarity, with initial announcements being later corrected by subsequent statements.

However, reports coming from the White House, Trump’s personal doctor, and WRMC spokespeople appear to converge on the president’s treatment strategy including three specific therapies:

Remdesivir, an antiviral
Dexamethasone, an anti-inflammatory
REGN-COV2, an antibody cocktail from Regeneron.

To date, there are no drugs approved by the US Food and Drug Administration (FDA) to treat and/or cure the virus, although Regeneron is one of the antibody cocktails in the running as a hopeful therapy (another being a similar product from Lilly).

The following are the latest articles from Outsourcing-Pharma and BioPharma-Reporter on the drugs reportedly given to Trump in an attempt to get a handle on his COVID-19 case and varying symptoms.